Spectrum Pharma

Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of a pipeline of novel and targeted oncology therapies. Its product pipeline includes: Eflapegrastim, Poziotinib, and IGN002. The company was founded in December 1987 and is headquartered in Henderson, NV.

Earnings data Q1 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Spectrum Pharmaceuticals is a biopharmaceutical company that focuses on acquiring, developing, and commercializing novel and targeted drug products, with a primary focus on oncology. It has a strong track record for in-licensing and acquiring differentiated drugs, and for clinical development.

HC Wainwright reiterates the Buy rating on Spectrum Pharmaceuticals Inc (NASDAQ: SPPI), with a price target of $10. The analyst projects revenues of $170 million for Rolontis and $328 million for poziotinib in 2026.

HC Wainwright Sees Almost 1000% Upside On Spectrum Pharma Stock

Spectrum Pharmaceuticals, Inc. (SPPI) CEO Tom Riga on Q4 2021 Results - Earnings Call Transcript

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Corporate Update

Spectrum Pharmaceuticals Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Corporate Update

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update

Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Appoints Juhyun Lim of Hanmi Pharmaceutical to Board of Directors

Spectrum Pharmaceuticals Appoints Juhyun Lim of Hanmi Pharmaceutical to Board of Directors

HENDERSON, Nev.--(BUSINESS WIRE)-- #ESMOTAT22--Spectrum Pharmaceuticals Presents Positive Data for Poziotinib in First-line NSCLC Patients with HER2 Exon 20 Insertion Mutations

Spectrum Pharmaceuticals Presents Positive Data for Poziotinib in First-line NSCLC Patients with HER2 Exon 20 Insertion Mutations

HENDERSON, Nev.--(BUSINESS WIRE)---- $SPPI #ESMOTAT22--Spectrum Pharmaceuticals Announces an Oral Poziotinib Presentation at the Upcoming ESMO TAT 2022 Virtual Meeting

Spectrum Pharmaceuticals Announces an Oral Poziotinib Presentation at the Upcoming ESMO TAT 2022 Virtual Meeting

Mullen Automotive

Evolve Transition Infrastructure LP

3 Penny Stocks to Watch Under $1 The post Best Penny Stocks To Buy Now? 3 Reddit Stocks To Watch Under $1 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Best Penny Stocks To Buy Now? 3 Reddit Stocks To Watch Under $1

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Announces Acceptance of New Drug Application Filing for Poziotinib

Spectrum Pharmaceuticals Announces Acceptance of New Drug Application Filing for Poziotinib

Biofrontera

Outlook Therapeutics Inc

Are these on your list of penny stocks to watch right now? The post 3 Top Penny Stocks To Buy For Under $5 Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Top Penny Stocks To Buy For Under $5 Today

The heavy selling pressure might have exhausted for Spectrum Pharma (SPPI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Down 55.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Spectrum Pharma (SPPI)

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Participate in B. Riley Securities 2022 Virtual Oncology Conference

Spectrum Pharmaceuticals to Participate in B. Riley Securities 2022 Virtual Oncology Conference

The stock price of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) fell by 11.19% in the most recent trading session. This is why it happened.

Spectrum Pharmaceuticals Stock (SPPI): Why The Price Fell

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Announces Strategic Restructuring

Spectrum Pharmaceuticals Announces Strategic Restructuring

Denison Mines

Farmmi

Which penny stocks are you watching this month? The post Trending Penny Stocks to Watch in January 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Trending Penny Stocks to Watch in January 2022

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Announces New Strategic Investment by Hanmi Pharmaceutical

Spectrum Pharmaceuticals Announces New Strategic Investment by Hanmi Pharmaceutical

Investors need to pay close attention to Spectrum Pharmaceuticals (SPPI) stock based on the movements in the options market lately.

Do Options Traders Know Something About Spectrum Pharmaceuticals (SPPI) Stock We Don't?

Bluejay Diagnostics

Bit Brother Ltd

BeyondSpring

Invacare

NuZee, Inc.

OPKO Health

PetVivo Holdings

Petros Pharmaceuticals

Ring Energy

Looking for potential short squeeze penny stocks? Start by looking at short interest The post Best Penny Stocks To Buy Now?

Best Penny Stocks To Buy Now? 10 Short Squeeze Stocks To Watch

Down 38% in 4 Weeks, Here's Why You Should You Buy the Dip in Spectrum Pharma (SPPI)

The stock price of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) increased by over 2% pre-market today. This is why it happened.

Spectrum Pharmaceuticals Stock (SPPI): Why The Price Increased

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib

Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Announces Changes to Management Team and Board of Directors

Spectrum Pharmaceuticals Announces Changes to Management Team and Board of Directors

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Participate in JMP Securities Hematology and Oncology Summit

Spectrum Pharmaceuticals to Participate in JMP Securities Hematology and Oncology Summit

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Participate in 2021 Jefferies London Healthcare Conference

Spectrum Pharmaceuticals to Participate in 2021 Jefferies London Healthcare Conference

Spectrum Pharmaceuticals, Inc.'s (SPPI) CEO Joseph Turgeon on Q3 2021 Results - Earnings Call Transcript

News for Spectrum Pharma Stock (SPPI)